Serum voriconazole levels following administration via percutaneous jejunostomy tube

被引：11

作者：

Martinez, V

Le Guillou, JL

Lamer, C ^{[1
]}

Le Jouan, M

Tod, M

Dromer, FO

机构：

[1] Inst Mutualiste Montsouris, F-75674 Paris 14, France

[2] Hop Cochin, F-75014 Paris, France

[3] Inst Pasteur, Unite Mycol Mol, Ctr Natl Reference Mycol & Antifong, F-75724 Paris 15, France

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2003年 / 47卷 / 10期

关键词：

D O I：

10.1128/AAC.47.10.3375.2003

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：3375 / 3375

页数：1

共 9 条

[1] Voriconazole (UK-109,496) inhibits the growth and alters the morphology of fluconazole-susceptible and -resistant Candida species [J].

Belanger, P ;

Nast, CC ;

Fratti, R ;

Sanati, H ;

Ghannoum, M .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (08) :1840-1842

[2] Candida glabrata:: Review of epidemiology, pathogenesis, and clinical disease with comparison to C-albicans [J].

Fidel, PL ;

Vazquez, JA ;

Sobel, JD .

CLINICAL MICROBIOLOGY REVIEWS, 1999, 12 (01) :80-+

[3] Ciprofloxacin absorption is impaired in patients given enteral feedings orally and via gastrostomy and jejunostomy tubes [J].

Healy, DP ;

Brodbeck, MC ;

Clendening, CE .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (01) :6-10

[4] Effects of voriconazole on Candida glabrata in vitro [J].

Koul, A ;

Vitullo, J ;

Reyes, G ;

Ghannoum, M .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (01) :109-112

[5] Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection [J].

Lewis, RE ;

Kontoyiannis, DP ;

Darouiche, RO ;

Raad, II ;

Prince, RA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) :3499-3505

[6] In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp. [J].

Pfaller, MA ;

Messer, SA ;

Hollis, RJ ;

Jones, RN ;

Diekema, DJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (06) :1723-1727

[7] Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi:: Report from SENTRY Antimicrobial Surveillance Program, 2000 [J].

Pfaller, MA ;

Messer, SA ;

Hollis, RJ ;

Jones, RN .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (04) :1032-1037

[8] Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens [J].

Purkins, L ;

Wood, N ;

Ghahramani, P ;

Greenhalgh, K ;

Allen, MJ ;

Kleinermans, D .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) :2546-2553

[9] Nosocomial Candida glabrata colonization:: an epidemiologic study [J].

Vazquez, JA ;

Dembry, LM ;

Sanchez, V ;

Vazquez, MA ;

Sobel, JD ;

Dmuchowski, C ;

Zervos, MJ .

JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (02) :421-426

← 1 →